Pharmaceuticals, Biotechnology and Life Sciences
Combined organization brings broader predictive capabilities to drug discovery at scale Reiterates full year 2024 guidance RADNOR, Pa., July 09,…
NEW YORK, July 08, 2024 (GLOBE NEWSWIRE) — Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines for inflammatory…
SPRING, Texas, July 08, 2024 (GLOBE NEWSWIRE) — Io Therapeutics, Inc., presented today results from studies done in breast, lung,…
DUBAI, United Arab Emirates, July 07, 2024 (GLOBE NEWSWIRE) — At DP World’s Aviv Clinics Dubai, the world’s most advanced…
VALNEVA Declaration of shares and voting rights June 30, 2024__________________________________________________________________________________________ Company name: VALNEVARegistered office: 6 rue Alain Bombard, 44800 Saint-Herblain…
Oxurion announces the results of the Extraordinary General Meeting (EGM) held on 4 July 2024 and convenes a new EGM…
Sheridan, Wyoming, USA, July 04, 2024 (GLOBE NEWSWIRE) — Rafarma Pharmaceuticals (OTC: RAFA) – Rafarma Pharmaceuticals is pleased to announce…
SKYSCRAPER-06 evaluating tiragolumab plus Tecentriq and chemotherapy did not meet the primary endpoints of progression-free survival at primary analysis and…
NEW YORK, July 03, 2024 (GLOBE NEWSWIRE) — Psyence Biomedical Ltd. (the “Company”) (Nasdaq: PBM) announced that it received a…
HONG KONG and SHANGHAI and FLORHAM PARK, N.J., July 04, 2024 (GLOBE NEWSWIRE) — HUTCHMED (China) Limited (“HUTCHMED”) (Nasdaq/AIM:HCM; HKEX:13)…